Navigation Links
Phoenix conference highlights TGen's and Scottsdale Healthcare's contributions to molecular oncology

PHOENIX, Ariz. Jan. 8, 2009 Physician-scientists from the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare will present their latest findings and techniques at a national conference designed to provide cancer doctors with new treatments for their patients.

"Molecular Oncology: The Sixth Vital Sign, What Every Oncologist Should Know" is intended to help cancer doctors provide better diagnosis, early detection as well as drugs and other treatments that in some cases can slow the growth or even shrink tumors.

"Given the explosion of new information on the genetic and cellular features of malignancy, the modern oncologist must master the significance and application of cancer-related sciences,'' said Dr. Ramesh K. Ramanathan, Medical Director of TGen Clinical Research Services at Scottsdale Healthcare, a partnership between TGen and Scottsdale Healthcare Corp.

Beyond the five vital signs of pulse, respiration, temperature, blood pressure and pain, is a new sixth vital sign molecular therapeutics. This is the ability to identify the causes of disease at the molecular level in order to provide the right drugs in the right amounts at the right times for the specific needs of individual patients; what is becoming better known in health circles as personalized medicine.

"This gap in knowledge and its application in clinical practice will be addressed in this conference,'' said Dr. Ramanathan, a Senior Investigator at TGen.

Dr. Ramanathan is the co-program director of the conference, along with Dr. Daniel Von Hoff, TGen's Physician-In-Chief and the Chief Scientific Officer at TCRS. Both doctors conduct groundbreaking personalized-medicine research and clinical drug trials at TCRS in Scottsdale, and both are on the clinical faculty of the University of Arizona College of Medicine. Both will present at the conference.

Other TGen and Scottsdale Healthcare scientists scheduled to present include: Dr. Jeffrey Trent, TGen's President and Scientific Director; Dr. Raoul Tibes, Director of the Hematological Malignancies Program at TCRS and an Associate Investigator at TGen; Dr. Stephen P. Anthony, Chief Medical Officer of TGen Drug Development Services (TD2) and a Senior Investigator at TGen; Dr. John Carpten, Director of TGen's Integrated Cancer Genomics Division and a Senior Investigator at TGen; and Gayle Jameson, M.S.N., Director of Supportive Care at TCRS and an Associate Investigator at TGen.

Besides oncologists, the target audience includes all physicians and health professionals involved in caring for cancer patients, and researchers interested in new cancer diagnostics and therapeutics.

Key objectives of the conference include:

  • Explaining the molecular and cellular features of malignancy in diagnostic and therapeutic approaches to the treatment of cancer, and identifying new diagnostic tools.

  • Assessing the effects and early clinical results of new, targeted drug therapies on solid tumors and malignant blood cancers.

  • Identifying new drug therapies that optimize treatment results and minimize side effects in specific biologic and clinical scenarios.

  • Evaluating clinical trials and translational methods of care and their proper use in clinical decision-making and patient management.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. Phoenix mission to Mars will search for climate clues
2. Atmel and Phoenix Technologies Collaborate to Create Next-generation Security Solutions for PCs
3. Phoenix Technologies and Atmel Collaborate to Create Next-Generation Security Solutions for PCs
4. Harmonizing Biobank Research Conference in 2009
5. PNNL researchers earn top honors at Supercomputing conference
6. Conference to explore sustainability of biofuels
7. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
8. Major conference on food Dec. 1-2, 2008
9. PNNL leadership in carbon sequestration featured at international conference
10. Engineer to present leak-proof method for carbon dioxide storage at international conference
11. Marine invasive species advance 50 km per decade, World Conference on Marine Biodiversity told
Post Your Comments:
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/17/2015)... EASTON, Mass. , Nov. 17, 2015 ... a leader in the development and sale of broadly ... the worldwide life sciences industry, today announced it has ... of its $5 million Private Placement (the "Offering"), increasing ... to $4,025,000.  One or more additional closings are expected ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing ... Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum of ... with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, ...
Breaking Biology Technology: